Launched in 2020, CL Biologics (CLB) is a premier biologics contract development and manufacturing organization (CDMO). Led by an experienced international team, CLB offers comprehensive CDMO services featuring:
• World-Class Facilities: State-of-the-art infrastructure
• Robust Process Design: Efficient and innovative
• Digital Quality Systems: Advanced and precise
• Global Compliance: Adherence to cGMP and international regulations
Currently, CLB is constructing advanced CDMO plants in Shenzhen and Shanghai, targeting over 700kL capacity by 2026.
CLB is committed to innovation, quality, and enhancing global healthcare outcomes.
Mission: Enabling High Quality, Affordable Biologics Worldwide
Company Details
- Employees
- 158
- Founded
- -
- Address
- Baguang International Biovalley, Shenzhen,china
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://clbiologics.com
- Keywords
- Biologics, CDMO, cGMP, CMO, FDA, IND, Biotechnology.
- HQ
- Shenzhen
Cl Biologics Questions
Cl Biologics's website is https://clbiologics.com
Cl Biologics's LinkedIn profile is https://www.linkedin.com/company/clbiologics
Cl Biologics has
158 employees.
View email and phone details for 158
employees at Cl Biologics.
Cl Biologics's industry is
Biotechnology Research
Cl Biologics's top competitors are
Hna Trust Management,
Samsung Biologics,
Asymchem Group,
Trilink Biotechnologies, Part Of Maravai Lifesciences,
Fosun Pharma,
Aprogen,
Lotte Biologics,
Dymind,
Ellab,
Beigene.
Cl Biologics's categories are Biotechnology Research
Cl Biologics's founding year is 2020
